EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old
- Ioana Agache
- , Cezmi A. Akdis
- , Mubeccel Akdis
- , Knut Brockow
- , Tomas Chivato
- , Stefano del Giacco
- , Thomas Eiwegger
- , Kilian Eyerich
- , Ana Giménez-Arnau
- , Jan Gutermuth
- , Emma Guttman-Yassky
- , Marcus Maurer
- , Graham Ogg
- , Peck Y. Ong
- , Liam O’Mahony
- , Jürgen Schwarze
- , Amena Warner
- , Thomas Werfel
- , Oscar Palomares
- , Marek Jutel
- Transilvania University of Brasov
- University of Zurich
- Christine Kühne-Center for Allergy Research and Education (CK-CARE)
- Technical University of Munich
- CEU Universities
- University of Cagliari
- University of Toronto
- Karl Landsteiner University of Health Sciences
- Autonomous University of Barcelona
- Vrije Universiteit Brussel
- Icahn School of Medicine at Mount Sinai
- Charité – Universitätsmedizin Berlin
- University of Oxford
- University of Southern California
- University of Edinburgh
- Allergy UK
- Hannover Medical School
- Complutense University
- Wrocław Medical University
Research output: Contribution to journal › Article › peer-review